Skip to main content
. 2017 Jun 21;152(10):938–943. doi: 10.1001/jamasurg.2017.1673

Table 2. Bivariate Analysis of Risk Factors for Mortality.

Risk Factor Patient Group
General Surgical Pretransplant
No. of Patients
(N = 53)
Mortality, No. (%) OR (95% CI) P Value No. of Patients
(N = 55)
Mortality, No. (%) OR (95% CI) P Value
Age ≥65 y
Yes 32 20 (62.53) 1.83 (0.60-5.60) .29 10 6 (60) 1.56 (0.39-6.32) .53
No 21 10 (47.6) 45 22 (48.9)
White
Yes 38 24 (63.2) 2.57 (0.76-8.76) .13 48 25 (52.1) 1.45 (0.29-7.18) .65
No 15 6 (40) 7 3 (42.8)
Male
Yes 29 16 (55.2) 0.88 (0.30-2.62) .82 35 18 (51.4) 1.06 (0.35-3.18) .92
No 24 14 (58.3) 20 10 (50)
BMI ≥30
Yes 8 5 (62.5) 1.33 (0.28-6.27) .72 18 9 (50) 0.95 (0.31-2.92) .93
No 45 25 (55.6) 37 19 (51.4)
APACHE IV score ≥25a
Yes 30 15 (50) 0.58 (0.18-1.89) .37 26 14 (53.8) 1.26 (0.43-3.70) .68
No 19 12 (63.2) 27 13 (48.2)
History of CKD
Yes 20 12 (60) 1.25 (0.41-3.86) .70 10 4 (40) 0.58 (0.15-2.34) .45
No 33 18 (54.5) 45 24 (53.3)
History of IHD
Yes 20 11 (55) 0.90 (0.29-2.76) .85 7 2 (28.6) 0.34 (0.06-1.92) .21
No 33 19 (57.6) 48 26 (54.2)
IHD preceding CRRT in SICU
Yes 7 7 (100) 1.30 (1.07-1.60) .01 7 4 (57.1) 1.33 (0.27-6.61) .72
No 46 23 (50) 48 24 (50)
Mechanical ventilation
Yes 50 28 (56) 0.64 (0.05-7.48) .72 53 27 (50.9) 1.04 (0.06-17.49) .98
No 3 2 (66.7) 2 1 (50)
Use of vasopressors during CRRT
Yes 45 28 (62.2) 4.94 (0.89-27.32) .07 35 22 (62.9) 3.95 (1.22-12.81) .02
No 8 2 (25) 20 6 (30)

Abbreviations: APACHE IV, Acute Physiology and Chronic Health Evaluation version IV; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CKD, chronic kidney disease; CRRT, continuous renal replacement therapy; IHD, intermittent hemodialysis; OR, odds ratio; SICU, surgical intensive care unit.

a

Calculated using preexisting comorbidities, acute diagnosis, and variables related to acute physiology. Increases in the score are associated with increased risk of mortality (scores range from 0 to 286).